The Underlying Molecular Mechanism of Apolipoprotein E Polymorphism: Relationships to Lipid Disorders, Cardiovascular Disease, and Alzheimer’s Disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Beisiegel, 1989, The LDL-receptor-related protein, LRP, is an apolipo-protein E binding protein, Nature, 341, 162, 10.1038/341162a0
Boerwinkle, 1988, Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism, Am J Hum Genet, 42, 104
Boerwinkle, 1991, Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol, Am J Hum Genet, 49, 1145
Brown, 1986, A receptor-mediated pathway for cholesterol homeostasis, Science, 232, 34, 10.1126/science.3513311
Carmena, 1993, The response to lovastatin in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism, Metabolism, 42, 895, 10.1016/0026-0495(93)90066-W
Clavel, 1995, Rapid and safe determination of human apolipoprotein E genotypes by miniaturised SDS-PAGE in non-insulin dependent diabetes mellitus, J Clin Pathol, 48, 295, 10.1136/jcp.48.4.295
Cobb, 1991, Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels, Circulation, 86, 145
Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science, 261, 921, 10.1126/science.8346443
Couderc, 1993, Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: A case-control study, Stroke, 24, 661, 10.1161/01.STR.24.5.661
Cumming, 1984, Polymorphism at the apoprotein-E locus in relation to risk of coronary disease, Clin Genet, 25, 310, 10.1111/j.1399-0004.1984.tb01995.x
Dallongeville, 1992, Modulation of plasma triglyceride levels by apo E phenotype: A meta-analysis, J Lipid Res, 33, 447, 10.1016/S0022-2275(20)41611-6
Davignon, 1987, Apolipoprotein E polymorphism and atherosclerosis: Insight from a study in octogenarians, Trans Am Clin Climatol/Assoc, 99, 100
Davignon, 1988, Apolipoprotein E polymorphism and atherosclerosis, Arteriosclerosis, 8, 1, 10.1161/01.ATV.8.1.1
DeKnijff, 1990, Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia, Atherosclerosis, 83, 89, 10.1016/0021-9150(90)90134-5
DeKnijff, 1994, Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels, Hum Mutation, 4, 178, 10.1002/humu.1380040303
Demant, 1991, Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects, J Clin Invest, 88, 1490, 10.1172/JCI115459
Despres, 1993, Apolipoprotein E polymorphism modifies relation of hyperinsulinemia to hypertriglyceridemia, Diabetes, 42, 1474, 10.2337/diab.42.10.1474
Dong, 1990, Enhanced binding activity of an apo E mutant, apo E5, to LDL receptors on human fibroblasts, Biochem Biophys Res Commun, 168, 409, 10.1016/0006-291X(90)92336-X
Ehnholm, 1986, Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentrations, J Lipid Res, 27, 227, 10.1016/S0022-2275(20)38833-7
Eichner, 1993, Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease, Am J Cardiol, 71, 160, 10.1016/0002-9149(93)90732-R
Eto, 1989, Increased frequencies of apolipoprotein e2 and e4 alleles in patients with ischemic heart disease, Clin Genet, 36, 183, 10.1111/j.1399-0004.1989.tb03186.x
Eto, 1990, Effects of probucol on plasma lipids and lipoprotein in familial hypercholesterolemic patients with and without apolipoprotein E4, Atherosclerosis, 84, 49, 10.1016/0021-9150(90)90007-6
Fisher, 1983, Independent effects of dietary saturated fat and cholesterol on plasma lipids, lipoproteins, and apolipoprotein E, J Lipid Res, 24, 1039, 10.1016/S0022-2275(20)37918-9
Gaddi, 1991, Dietary treatment for familial hypercholesterolemia—differential effects of dietary soy protein according to the apolipoprotein E phenotypes, Am J Clin Nutr, 53, 1191, 10.1093/ajcn/53.5.1191
Gåfvels, 1993, Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23, Somat Cell Mol Genet, 19, 557, 10.1007/BF01233382
Ghiselli, 1981, Type III hyperlipoproteinemia associated with plasma apolipoprotein E deficiency, Science, 214, 1239, 10.1126/science.6795720
Ghiselli, 1984, Apolipoprotein EBethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins, Biochim Biophys Acta, 794, 333, 10.1016/0005-2760(84)90164-4
Gregg, 1986, Abnormal in vivo metabolism of apolipoprotein E4 in humans, J Clin Invest, 78, 815, 10.1172/JCI112645
Haffner, 1992, Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: Influence of apolipoprotein E-3/E-2 pattern, Metabolism, 41, 241, 10.1016/0026-0495(92)90265-C
Havel, 1973, Primary dysbetalipoproteinemia: Predominance of a specific apoprotein species in triglyceride-rich lipoproteins, Proc Natl Acad Sci USA, 70, 2015, 10.1073/pnas.70.7.2015
Havel, 1983, Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3, J Clin Invest, 72, 379, 10.1172/JCI110978
Havekes, 1986, Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia, Hum Genet, 73, 157, 10.1007/BF00291607
Hill, 1991, Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia, Arterioscler Thromb, 11, 290, 10.1161/01.ATV.11.2.290
Hixson, 1991, Apolipoprotein E polymorphism affects atherosclerosis in young males, Arterioscler Thromb, 11, 1237, 10.1161/01.ATV.11.5.1237
Hopkins, 1991, Type III hyperlipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2: Evidence for a gene-gene interaction, Arterioscler Thromb, 11, 1137, 10.1161/01.ATV.11.5.1137
Jenkins, 1993, The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiber, Metabolism, 42, 585, 10.1016/0026-0495(93)90217-C
Jones, 1992, Cholesterol and triglyceride fatty acid synthesis in apolipoprotein E2-associated hyperlipidemia, Arterioscler Thromb, 12, 106, 10.1161/01.ATV.12.1.106
Kamboh, 1993, Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites, Atherosclerosis, 98, 201, 10.1016/0021-9150(93)90129-I
Koller, 1995, Apolipoprotein E genotypes in Parkinson’s disease with and without dementia, Ann Neurol, 37, 242, 10.1002/ana.410370215
Kurosaka, 1991, Apolipoprotein E deficiency with a depressed mRNA of normal size, Atherosclerosis, 88, 15, 10.1016/0021-9150(91)90252-X
Kuusi, 1989, Apoprotein E polymorphism and coronary artery disease: Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients, Arteriosclerosis, 9, 237, 10.1161/01.ATV.9.2.237
Lenzen, 1986, Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease, Clin Chem, 32, 778, 10.1093/clinchem/32.5.778
Liddell, 1994, Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer’s disease, J Med Genet, 31, 197, 10.1136/jmg.31.3.197
Lopez-Miranda, 1994, Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol, J Lipid Res, 35, 1965, 10.1016/S0022-2275(20)39943-0
Mabuchi, 1989, A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency, Metabolism, 38, 115, 10.1016/0026-0495(89)90249-7
Maeda, 1989, Identification of human apolipoprotein E variant gene: Apolipoprotein E7 (Glu244, 245→Lys244, 245), J Biochem, 105, 51, 10.1093/oxfordjournals.jbchem.a122618
Maeda, 1989, Molecular cloning of a human apolipoprotein E variant: E5 (Glu3→Lys3), J Biochem, 105, 491, 10.1093/oxfordjournals.jbchem.a122692
Mahley, 1988, Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology, Science, 240, 622, 10.1126/science.3283935
Mahley, 1989, Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipid metabolism, 1195
Mahley, 1991, Genetic defects in lipoprotein metabolism: Elevation of atherogenic lipoproteins caused by impaired catabolism, JAMA, 265, 78, 10.1001/jama.1991.03460010078035
Mänttäri, 1991, Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention, Metabolism, 40, 217, 10.1016/0026-0495(91)90179-Z
Martin, 1993, Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: Relationship to apolipoprotein E genotype, J Lipid Res, 34, 437, 10.1016/S0022-2275(20)40735-7
Mayeux, 1993, The apolipoprotein e4 allele in patients with Alzheimer’s disease, Ann Neurol, 34, 752, 10.1002/ana.410340527
McLean, 1984, Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant, J Biol Chem, 259, 6498, 10.1016/S0021-9258(20)82169-3
Menzel, 1983, Apolipoprotein E polymorphism and coronary artery disease, Arteriosclerosis, 3, 310, 10.1161/01.ATV.3.4.310
Miettinen, 1988, Serum cholesterol response to dietary cholesterol and apoprotein E phenotype, Lancet, 2, 1261, 10.1016/S0140-6736(88)90862-8
Namba, 1991, Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease, Brain Res, 541, 163, 10.1016/0006-8993(91)91092-F
Nestruck, 1987, Apolipoprotein E polymorphism and plasma cholesterol response to probucol, Metabolism, 36, 743, 10.1016/0026-0495(87)90110-7
Nieminen, 1991, Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease, Arterioscler Thromb, 12, 58, 10.1161/01.ATV.12.1.58
Noguchi, 1993, Apolipoprotein E genotype and Alzheimer’s disease, Lancet, 342, 737, 10.1016/0140-6736(93)91728-5
O’Malley, 1990, The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia, Metabolism, 39, 150, 10.1016/0026-0495(90)90068-N
Orchard, 1994, Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial, Ann Epidemiol, 4, 40, 10.1016/1047-2797(94)90041-8
Ordovas, 1987, Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoEl and apoE5 isoforms, J Lipid Res, 28, 371, 10.1016/S0022-2275(20)38690-9
Pedro-Botet, 1992, Lipoprotein and apolipoprotein profile in men and ischemic stroke: Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism, Stroke, 23, 1556, 10.1161/01.STR.23.11.1556
Petersen, 1995, Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals, JAMA, 273, 1274, 10.1001/jama.1995.03520400044042
Poirier, 1993, Apolipoprotein E polymorphism and Alzheimer’s disease, Lancet, 342, 697, 10.1016/0140-6736(93)91705-Q
Rail, 1982, Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects, Proc Natl Acad Sci USA, 79, 4696, 10.1073/pnas.79.15.4696
Rail, 1982, Human apolipoprotein E: The complete amino acid sequence, J Biol Chem, 257, 4171, 10.1016/S0021-9258(18)34702-1
Rail, 1983, Identification of a new structural variant of human apolipoprotein E, E2(Lys146→Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype, J Clin Invest, 72, 1288, 10.1172/JCI111085
Rail, 1989, Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant, J Clin Invest, 83, 1095, 10.1172/JCI113988
Richard, 1994, Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA, Clin Chem, 40, 24, 10.1093/clinchem/40.1.24
Saunders, 1993, Apolipoprotein E e4 allele distributions in late-onset Alzheimer’s disease and in other amyloid-forming diseases, Lancet, 342, 710, 10.1016/0140-6736(93)91709-U
Saunders, 1993, Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease, Neurology, 43, 1467, 10.1212/WNL.43.8.1467
Savolainen, 1991, Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype, Atherosclerosis, 86, 145, 10.1016/0021-9150(91)90210-T
Schachter, 1994, Genetic associations with human longevity at the apoE and ACE loci, Nature Genetics, 6, 29, 10.1038/ng0194-29
Sentí, 1992, Lipoprotein profile in men with peripheral vascular disease: Role of intermediate density lipoproteins and apoprotein E phenotypes, Circulation, 85, 30, 10.1161/01.CIR.85.1.30
Sing, 1985, Role of apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation, Am J Hum Genet, 37, 268
Strittmatter, 1993, Apolipoprotein E: High avidity binding to ß-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci USA, 90, 1977, 10.1073/pnas.90.5.1977
Strittmatter, 1993, Binding of human apolipoprotein E to synthetic amyloid ß peptide: Isoform-specific effects and implications for late-onset Alzheimer disease, Proc Natl Acad Sci USA, 90, 8098, 10.1073/pnas.90.17.8098
Stuyt, 1991, Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease, Scand J Clin Lab Invest, 51, 425, 10.3109/00365519109091636
Tajima, 1988, Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia, J Biochem, 104, 48, 10.1093/oxfordjournals.jbchem.a122420
Tajima, 1989, Analysis of apolipoprotein E7 (apolipoprotein E-Suita) gene from a patient with hyperlipoproteinemia, J Biochem, 105, 249, 10.1093/oxfordjournals.jbchem.a122648
Tikkanen, 1990, Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet, Arteriosclerosis, 10, 285, 10.1161/01.ATV.10.2.285
Ukkola, 1993, Apolipoprotein E phenotype is related to macro-and microangiopathy in patients with non-insulin-dependent diabetes mellitus, Atherosclerosis, 101, 9, 10.1016/0021-9150(93)90096-D
Utermann, 1977, Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man, Nature, 269, 604, 10.1038/269604a0
Utermann, 1984, Apolipoprotein E phenotypes in patients with myocardial infarction, Hum Genet, 65, 237, 10.1007/BF00286509
Utermann, 1987, Apolipoprotein E polymorphism in health and disease, Am Heart J, 113, 433, 10.1016/0002-8703(87)90610-7
van Bockxmeer, 1992, Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease, Lancet, 340, 879, 10.1016/0140-6736(92)93288-X
Vitale, 1990, Lipoprotein abnormalities in patients with extracoronary arteriosclerosis, Atherosclerosis, 81, 95, 10.1016/0021-9150(90)90015-B
Wardell, 1987, Apolipoprotein E2-Christchurch (136Arg→Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia, J Clin Invest, 80, 483, 10.1172/JCI113096
Wardell, 1991, Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity, J Lipid Res, 32, 521, 10.1016/S0022-2275(20)42076-0
Warnick, 1979, Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3, Clin Chem, 25, 279, 10.1093/clinchem/25.2.279
Weisgraber, 1981, Human E apoprotein heterogeneity: cystiene-arginine interchanges in the amino acid sequence of the apo E isoforms, J Biol Chem, 256, 9077, 10.1016/S0021-9258(19)52510-8
Weisgraber, 1982, Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site, J Biol Chem, 257, 2518, 10.1016/S0021-9258(18)34954-8
Weisgraber, 1984, A novel electrophoretic variant of human apolipoprotein E. Isolation and characterization of apolipoprotein El, J Clin Invest, 73, 1024, 10.1172/JCI111287
Weissfeld, 1992, Precision of blood cholesterol measurement and high blood cholesterol case-finding and treatment, J Clin Epidemiol, 45, 971, 10.1016/0895-4356(92)90113-2
Wilson, 1994, Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: The Framingham offspring study, JAMA, 272, 1666, 10.1001/jama.1994.03520210050031
Wisniewski, 1993, Apolipoprotein E: binding to soluble Alzheimer’s ß-amyloid, Biochem Biophys Res Comm, 192, 359, 10.1006/bbrc.1993.1423
Wu, 1994, Apolipoprotein E: laboratory determination and clinical significance, 279
Xhignesse, 1991, Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health, Arterioscler Thromb, 11, 1100, 10.1161/01.ATV.11.4.1100
Yamamoto, 1990, Risk factors for atherosclerotic vascular diseases with special reference to the relationship between apolipoprotein E mutations and hyperlipidemia, Ann NY Acad Sci, 598, 58, 10.1111/j.1749-6632.1990.tb42276.x
Yamamura, 1984, A new isoform of apolipoprotein E- Apo E5- associated with hyperlipidemia and atherosclerosis, Atherosclerosis, 50, 159, 10.1016/0021-9150(84)90019-4
Yamamura, 1984, New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia, J Clin Invest, 74, 1229, 10.1172/JCI111532
Yamamura, 1992, Apolipoprotein E polymorphism and coronary heart disease, Chin Med J, 105, 738
Zannis, 1985, Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages, Biochem, 24, 4450, 10.1021/bi00337a028
Zannis, 1989, Molecular biology of human apolipoproteins B and E and associated diseases of lipoprotein metabolism, Adv Lipid Res, 23, 1, 10.1016/B978-0-12-024923-7.50005-4